Table 2.
Completion of Dysglycemia Screening among Eligible Patients by Sociodemographic and Clinical Characteristics*
| Characteristic | All Eligible Patients (N = 89,543)† | ||
|---|---|---|---|
| Completed Screening (n = 53,263) |
Did Not Complete Screening (n = 36,280) |
P-value | |
| Mean age, years | 49.0 (9.2) | 49.3 (9.6) | 0.00 |
| Age categories, years | |||
| 35–39 | 9,952 (18.7) | 7,290 (20.1) | < 0.001 |
| 40–49 | 19,397 (36.4) | 11,990 (33.0) | < 0.001 |
| 50–64 | 20,891 (39.2) | 14,279 (39.4) | 0.84 |
| 65–70 | 3,023 (5.7) | 2,721 (7.5) | 0.01 |
| Sex | |||
| Male | 21,917 (41.2) | 17,459 (48.1) | < 0.001 |
| Female | 31,346 (58.8) | 18,821 (51.9) | < 0.001 |
| Race and ethnicity | |||
| Non-Hispanic Asian | 1,611 (3.0) | 1,187 (3.3) | 0.72 |
| Non-Hispanic Black | 14,858 (27.9) | 9,973 (27.5) | 0.55 |
| Hispanic/Latino | 23,188 (43.5) | 9,819 (27.1) | < 0.001 |
| Non-Hispanic White | 11,253 (21.1) | 13,475 (37.1) | < 0.001 |
| Other or unknown | 2,353 (4.4) | 1,826 (5.0) | 0.37 |
| Insurance status | |||
| Uninsured | 8,360 (15.7) | 6,921 (19.1) | < 0.001 |
| Medicaid | 9,033 (17.0) | 8,146 (22.4) | < 0.001 |
| Medicare | 12,589 (23.6) | 8,352 (23.0) | 0.37 |
| Private | 2,764 (5.2) | 2,549 (7.0) | 0.01 |
| Other or unknown | 20,526 (38.5) | 10,330 (28.5) | < 0.001 |
| Family history of diabetes | 507 (4.7) | 414 (2.2) | 0.03 |
| Hypertension | 35,355 (66.4) | 29,272 (80.7) | < 0.001 |
| Dyslipidemia | 28,201 (52.9) | 13,940 (38.4) | < 0.001 |
| Polycystic ovary syndrome‡ | 226 (0.7) | 107 (0.6) | 0.85 |
| Mean body mass index, kg/m2 | 33.0 (6.7) | 31.9 (6.2) | < 0.001 |
| Weight status | |||
| Normal | 0 (0.0) | 0 (0.0) | –- |
| Overweight | 20,378 (38.3) | 16,006 (45.8) | < 0.001 |
| Class 1 obesity | 17,113 (32.1) | 11,162 (30.8) | 0.05 |
| Class 2 obesity | 8,767 (16.5) | 4,962 (13.7) | < 0.001 |
| Class 3 obesity | 7,005 (13.2) | 3,550 (9.8) | < 0.001 |
| Mean number of office visits§ | 6.0 (5.2) | 4.7 (5.0) | < 0.001 |
| 1 office visit | 4,330 (8.1) | 7,505 (20.7) | < 0.001 |
| 2–3 office visits | 16,736 (31.4) | 12,332 (34.0) | < 0.001 |
| ≥ 4 office visits | 32,197 (60.5) | 16,443 (45.3) | < 0.001 |
* Unless noted otherwise, data are presented as column percentages for each of the patient characteristics. Percentages may not add to 100 due to rounding within strata of patient characteristics
† Screening eligibility was determined according to the 2021 USPSTF recommendation, namely age 35–70 years old and overweight or obesity
‡ The denominator for the reported proportions was the total number of women
§ The number of office visits were recorded during the entire study period from January 1, 2018 to December 31, 2020, during which screening completion was ascertained